Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Carisma Therapeutics Inc. (CARM) vs Trevena, Inc. (TRVN)

Carisma Therapeutics Inc. and Trevena, Inc. are both Biotechnology companies. Trevena, Inc. is the larger, with a market value of $1.8M against $1.5M — 1.2× the size. Carisma Therapeutics Inc. grew revenue faster over the last twelve months: 170.5% against −83.0%. Carisma Therapeutics Inc. has the higher net margin (14.4% vs −6,233.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Carisma Therapeutics Inc. leads on 10 and Trevena, Inc. on 5.

Valuation

Metric CARM TRVN Biotechnology median
P/E n/m n/m 7.88
P/S n/m 0.02 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales (0.05) 35.05 10.73
Earnings yield 0.00% (470,400.00%) (28.84%)
Free cash flow yield 0.00% (318,077.37%) (23.03%)

Profitability

Metric CARM TRVN Biotechnology median
Gross margin 100.00% (190.29%) 65.16%
Operating margin 19.36% (5,879.85%) 0.00%
Net margin 14.36% (6,233.70%) 0.00%
Free cash flow margin (38.79%) (4,961.72%) 0.00%
Return on equity (134.11%) 344.49% (57.72%)
Return on assets 33.09% (105.83%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CARM TRVN Biotechnology median
Revenue growth (TTM) 170.48% (82.97%) 5.64%
EPS growth (last fiscal year) 43.68% 58.37% —
Revenue growth, 5-year CAGR 115.24% (11.43%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CARM TRVN Biotechnology median
Debt to equity 0.00 (1.41) 0.00
Current ratio 0.86 2.42 4.73
Net debt to EBITDA 0.30 0.06 0.96

Dividend

Metric CARM TRVN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CARM TRVN Biotechnology median
Market cap 1.52m 1.81m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack